Literature DB >> 17701880

Weight-bearing intensity produces charcot deformity in injured neuropathic feet in diabetes.

R Kimmerle1, E Chantelau.   

Abstract

UNLABELLED: The purpose of the study was to investigate the relationship between the intensity of unrestrained weight bearing after a non-fracture injury (e.g. sprain), and the development of osteoarthropathic deformities of the foot (Charcot foot) in patients with diabetic neuropathy.
METHODS: 34 diabetic patients (14 Type 1, 20 Type 2) with foot bone injuries were studied in retrospect. At onset of injury symptoms (e.g. foot swelling), 32 of 34 feet displayed unremarkable X-ray, but pathologic MR imaging (e.g. bone marrow edema along the Lisfranc and/or the Chopart joint). Cumulative load forces after the onset of symptoms until treatment by total contact cast (TCC) were estimated using the product of body weight and number of weeks of ambulation (kg x week) as a surrogate. Feet were classified in 3 groups according to the degree of foot deformities found at the start of treatment with TCC: Feet without deformities (group A, n=16), feet with minor deformities (partially reduced plantar arch (group B, n=6) and feet with major deformities (collapsed plantar arch, group C, n=12)
RESULTS: Feet in group A had been exposed to 262 (95% CI 135-390) kg x week, compared to 974 (95% CI 342-1606) in group B, and to 2348 (95% CI 1265-3430) kg x week in group C (p<0.05 between groups), indicative of a dose-response relationship between weight-bearing and progressive foot deformities. Destruction along the Lisfranc joint was observed in 2/16 feet in group A, versus 18/18 feet in group B and C combined (p<0.001). In group A, the undeformed feet were healed without major deformities (except for 2 non-compliant patients), whereas in group B and C feet remained as deformed as they were at TCC application.
CONCLUSION: Unrestrained weight-bearing of injured foot bones and joints of more than 400 kg x week (equivalent to 8 weeks of normal walking by a person of 50 kg body weight) prompts Charcot deformities, with disintegration of the Lisfranc joint. Early off-loading by TCC treatment allows healing without deformities.

Entities:  

Mesh:

Year:  2007        PMID: 17701880     DOI: 10.1055/s-2007-970578

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  13 in total

1.  Sudeck's disease stage 1, or diabetic Charcot's foot stage 0? Case report and assessment of the diagnostic value of MRI.

Authors:  Ludger W Poll; Philipp Weber; Hermann-Josef Böhm; Nahid Ghassem-Zadeh; Ernst A Chantelau
Journal:  Diabetol Metab Syndr       Date:  2010-10-05       Impact factor: 3.320

2.  Classifications in brief: Eichenholtz classification of Charcot arthropathy.

Authors:  Andrew J Rosenbaum; John A DiPreta
Journal:  Clin Orthop Relat Res       Date:  2014-11-21       Impact factor: 4.176

Review 3.  The Charcot foot as a complication of diabetic neuropathy.

Authors:  Janice V Mascarenhas; Edward B Jude
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

4.  Should one consider primary surgical reconstruction in charcot arthropathy of the feet?

Authors:  Thomas Mittlmeier; K Klaue; Patrick Haar; Markus Beck
Journal:  Clin Orthop Relat Res       Date:  2009-07-14       Impact factor: 4.176

5.  Routine MRI findings of the asymptomatic foot in diabetic patients with unilateral Charcot foot.

Authors:  Ludger W Poll; Ernst A Chantelau
Journal:  Diabetol Metab Syndr       Date:  2010-04-22       Impact factor: 3.320

Review 6.  [Charcot foot. Current situation and outlook].

Authors:  T Mittlmeier; K Klaue; P Haar; M Beck
Journal:  Unfallchirurg       Date:  2008-04       Impact factor: 1.000

7.  Comparison of Arthrodesis with Total Contact Casting for Midfoot Ulcerations Associated with Charcot Neuroarthropathy.

Authors:  Yan Wang; Junlin Zhou; Fen Yan; Gong Li; Xiaofen Duan; Heng Pan; Jiao He
Journal:  Med Sci Monit       Date:  2015-07-24

8.  Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study.

Authors:  Danielle A Griffiths; Michelle R Kaminski
Journal:  J Foot Ankle Res       Date:  2021-06-15       Impact factor: 2.303

9.  A comparative study of zoledronic acid and once weekly Alendronate in the management of acute Charcot arthropathy of foot in patients with diabetes mellitus.

Authors:  R Bharath; Arun Bal; Shanmuga Sundaram; A G Unnikrishnan; V P Praveen; Nisha Bhavani; Vasantha Nair; R V Jayakumar; Harish Kumar
Journal:  Indian J Endocrinol Metab       Date:  2013-01

10.  Etiology, pathophysiology and classifications of the diabetic Charcot foot.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Diabet Foot Ankle       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.